Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Secretion”

290 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 290 results

Not applicableStudy completedNCT04495231
What this trial is testing

Sympathetic Activity and Cardiometabolic Complications

Who this might be right for
Catecholamine; OverproductionCatecholamine; SecretionMetabolic Syndrome+4 more
University of Turin, Italy 1,380
Post-approval studies (Phase 4)Ended earlyNCT02844907
What this trial is testing

Regulation of Insulin Secretion by the GLP-1 Receptor

Who this might be right for
Insulin Secretion
VA Office of Research and Development 6
Not applicableNot Yet RecruitingNCT07638111
What this trial is testing

SENSILINS: Impact of Cephalic Phase Insulin Release Induced by an Environmental Food Odor Stimulus on Glucose Homeostasis According to Insulin Sensitivity Level

Who this might be right for
Obesity & OverweightInsulin Resistance Syndrome
Hospices Civils de Lyon 20
Not applicableUnknownNCT05575206
What this trial is testing

The Influence of Genetic Variations in ELAPOR1 or ELAPOR2 on Insulin Secretion and Glucose Regulation in Humans

Who this might be right for
Type 2 DiabetesImpaired Insulin Secretion
University Hospital Tuebingen 20
Not applicableStudy completedNCT01145027
What this trial is testing

Cephalic Phase Insulin Secretion and Capillary Recruitment in Healthy Men

Who this might be right for
Microvascular Function
Rio de Janeiro State University 39
Testing effectiveness (Phase 2)Study completedNCT02621060
What this trial is testing

Effect of Chlorogenic Acid on Patients With Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
University of Guadalajara 30
Not applicableNot Yet RecruitingNCT06671340
What this trial is testing

Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

Who this might be right for
Diabetes MellitusPrediabetes / Type 2 Diabetes
Elaine Chow 30
Not applicableStudy completedNCT04332289
What this trial is testing

Assessing Insulin Turnover Using an In-vivo Deuterated Water Experiment.

Who this might be right for
Bariatric SurgeryHypoglycemiaGastric Bypass
Lia Bally 4
Testing effectiveness (Phase 2)Study completedNCT00279305
What this trial is testing

Rituximab in New Onset Type 1 Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 87
Not applicableUnknownNCT01960231
What this trial is testing

The Effect of ß-cell Specific Glucokinase Mutation on Glucose Homeostasis and Insulin Secretion in a MODY-2 Family

Who this might be right for
MODY-2 Diabetes
Sheba Medical Center 30
Post-approval studies (Phase 4)Study completedNCT00885638
What this trial is testing

Effects of Dipeptidyl Peptidase-4 (DPP-4) Inhibition on Hormonal Responses to Macronutrient Ingestion

Who this might be right for
HealthyType 2 Diabetes
Lund University 12
Large-scale testing (Phase 3)Study completedNCT00683735
What this trial is testing

Quantification of the Dipeptidyl Peptidase (DPP)-4 Inhibition-mediated Enhancement of the Activity of the Entero-insular Axis

Who this might be right for
Diabetes
Michael A. Nauck 20
Post-approval studies (Phase 4)UnknownNCT04135287
What this trial is testing

Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients

Who this might be right for
Diabetes Mellitus, Type 2
Dasman Diabetes Institute 315
Post-approval studies (Phase 4)Study completedNCT00131755
What this trial is testing

Efficacy of Diazoxide in Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1
Grill, Valdemar, M.D. 40
Large-scale testing (Phase 3)Study completedNCT02592421
What this trial is testing

SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

Who this might be right for
Type II Diabetes Mellitus
The University of Texas Health Science Center at San Antonio 30
Not applicableUnknownNCT02667964
What this trial is testing

FGF-21 and Exercise in Relation to Insulin Secretion

Who this might be right for
Physical Activity
Charite University, Berlin, Germany 60
Not applicableStudy completedNCT00849849
What this trial is testing

Comprehensive Postpartum Screening Strategies for Women With Gestational Diabetes Mellitus (GDM)

Who this might be right for
Diabetes Mellitus, Type 2
Woman's 214
Not applicableStudy completedNCT00469833
What this trial is testing

Insulin Secretion in Diabetes Before and After Glycemic Control

Who this might be right for
DiabetesHyperglycemia
US Department of Veterans Affairs 17
Testing effectiveness (Phase 2)Study completedNCT00947427
What this trial is testing

Canakinumab Study in Individuals With Newly Diagnosed Type 1 Diabetes

Who this might be right for
Type 1 DiabetesPreservation of Insulin SecretionNewly Diagnosed Type 1 Diabetes+1 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 71
Not applicableUnknownNCT01534442
What this trial is testing

Atropin and Glucose Stimulated Insulinsecretion and the Cephalic Insulin Response

Who this might be right for
The Focus of This Study is to Evaluete the Significances of the Vagal Cholinerg Nervuos System for the Effect of GLP-1 by Using Atropin Administration.
University Hospital, Gentofte, Copenhagen 10
Next Page